Advantages of switching to elvitegravir/cobicistat/emtricitabine/tenofovir therapy in virologically-suppressed people living with human immunodeficiency virus/acquired immune deficiency syndrome

• Lina Fan,
• Lei Li,
• Liying Gao,
• Yue Hu,
• Aiping Yu,
• Defa Zhang,
• Chunting Qiu,
• Rong Huang,
• Yue Wu,
• Ping Ma,
• Yanjie Yin

Affiliations

Lina Fan

Department of Infectious Diseases, Tianjin Second People's Hospital, Tianjin 300192, China.

Lei Li

Department of Infectious Diseases, Tianjin Second People's Hospital, Tianjin 300192, China.

Liying Gao

Department of Infectious Diseases, Tianjin Second People's Hospital, Tianjin 300192, China.

Yue Hu

Department of Infectious Diseases, Tianjin Second People's Hospital, Tianjin 300192, China.

Aiping Yu

Department of Infectious Diseases, Tianjin Second People's Hospital, Tianjin 300192, China.

Defa Zhang

Department of Infectious Diseases, Tianjin Second People's Hospital, Tianjin 300192, China.

Chunting Qiu

Department of Infectious Diseases, Tianjin Second People's Hospital, Tianjin 300192, China.

Rong Huang

Department of Infectious Diseases, Tianjin Second People's Hospital, Tianjin 300192, China.

Yue Wu

Department of Infectious Diseases, Tianjin Second People's Hospital, Tianjin 300192, China.

Ping Ma

Department of Infectious Diseases, Tianjin Second People's Hospital, Tianjin 300192, China.

Yanjie Yin

Department of Infectious Diseases, Tianjin Second People's Hospital, Tianjin 300192, China.